23andMe was once worth $6 billion. What's left of the DNA testing startup is being bought for $256 million.
Regeneron Pharmaceuticals is acquiring the remaining assets of 23andMe, the once-$6 billion DNA testing startup co-founded by Anne Wojcicki, for just $256 million as the company files for Chapter 11 bankruptcy.